Loading...

Aleafia Health

TSX:ALEF
Snowflake Description

Excellent balance sheet with high growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
ALEF
TSX
CA$357M
Market Cap
  1. Home
  2. CA
  3. Healthcare
Company description

Aleafia Health Inc. operates as an integrated cannabis health and wellness company. The last earnings update was 34 days ago. More info.


Add to Portfolio Compare Print
  • Aleafia Health has significant price volatility in the past 3 months.
ALEF Share Price and Events
7 Day Returns
-1.5%
TSX:ALEF
-0%
CA Healthcare
0.1%
CA Market
1 Year Returns
106.3%
TSX:ALEF
20.5%
CA Healthcare
-2.8%
CA Market
ALEF Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Aleafia Health (ALEF) -1.5% -20.7% -42.5% 106.3% - -
CA Healthcare -0% -2.9% -2.6% 20.5% -3.9% 26.8%
CA Market 0.1% -1.1% -0.4% -2.8% 11.5% 0.9%
1 Year Return vs Industry and Market
  • ALEF outperformed the Healthcare industry which returned 20.5% over the past year.
  • ALEF outperformed the Market in Canada which returned -2.8% over the past year.
Price Volatility
Industry
5yr Volatility vs Market

ALEF Value

 Is Aleafia Health undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Aleafia Health to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Aleafia Health.

TSX:ALEF Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 1 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 6.7%
Perpetual Growth Rate 10-Year CA Government Bond Rate 1.9%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for TSX:ALEF
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year CA Govt Bond Rate 1.9%
Equity Risk Premium S&P Global 6%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.64
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.638 (1 + (1- 26.5%) (5.91%))
0.776
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.8
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.95% + (0.8 * 5.96%)
6.72%

Discounted Cash Flow Calculation for TSX:ALEF using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Aleafia Health is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

TSX:ALEF DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (CAD, Millions) Source Present Value
Discounted (@ 6.72%)
2019 -39.40 Analyst x1 -36.92
2020 22.70 Analyst x1 19.93
2021 60.50 Analyst x1 49.78
2022 99.36 Est @ 64.23% 76.61
2023 144.62 Est @ 45.55% 104.49
2024 191.57 Est @ 32.47% 129.71
2025 236.22 Est @ 23.31% 149.88
2026 276.15 Est @ 16.9% 164.19
2027 310.43 Est @ 12.42% 172.96
2028 339.23 Est @ 9.27% 177.11
Present value of next 10 years cash flows CA$1,007.74
TSX:ALEF DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= CA$339.23 × (1 + 1.95%) ÷ (6.72% – 1.95%)
CA$7,253.16
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= CA$7,253.16 ÷ (1 + 6.72%)10
CA$3,786.80
TSX:ALEF Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= CA$1,007.74 + CA$3,786.80
CA$4,794.54
Equity Value per Share
(CAD)
= Total value / Shares Outstanding
= CA$4,794.54 / 274.76
CA$17.45
TSX:ALEF Discount to Share Price
Calculation Result
Value per share (CAD) From above. CA$17.45
Current discount Discount to share price of CA$1.30
= -1 x (CA$1.30 - CA$17.45) / CA$17.45
92.6%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Aleafia Health is available for.
Intrinsic value
>50%
Share price is CA$1.3 vs Future cash flow value of CA$17.45
Current Discount Checks
For Aleafia Health to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Aleafia Health's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Aleafia Health's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Aleafia Health's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Aleafia Health's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
TSX:ALEF PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in CAD CA$-0.27
TSX:ALEF Share Price ** TSX (2019-06-14) in CAD CA$1.3
Canada Healthcare Industry PE Ratio Median Figure of 7 Publicly-Listed Healthcare Companies 45.57x
Canada Market PE Ratio Median Figure of 546 Publicly-Listed Companies 15.02x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Aleafia Health.

TSX:ALEF PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TSX:ALEF Share Price ÷ EPS (both in CAD)

= 1.3 ÷ -0.27

-4.89x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Aleafia Health is loss making, we can't compare its value to the CA Healthcare industry average.
  • Aleafia Health is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does Aleafia Health's expected growth come at a high price?
Raw Data
TSX:ALEF PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -4.89x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
95.2%per year
North America Healthcare Industry PEG Ratio Median Figure of 47 Publicly-Listed Healthcare Companies 1.59x
Canada Market PEG Ratio Median Figure of 247 Publicly-Listed Companies 1.15x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Aleafia Health, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Aleafia Health's assets?
Raw Data
TSX:ALEF PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in CAD CA$1.42
TSX:ALEF Share Price * TSX (2019-06-14) in CAD CA$1.3
Canada Healthcare Industry PB Ratio Median Figure of 23 Publicly-Listed Healthcare Companies 2.35x
Canada Market PB Ratio Median Figure of 2,420 Publicly-Listed Companies 1.41x
TSX:ALEF PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TSX:ALEF Share Price ÷ Book Value per Share (both in CAD)

= 1.3 ÷ 1.42

0.91x

* Primary Listing of Aleafia Health.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Aleafia Health is good value based on assets compared to the CA Healthcare industry average.
X
Value checks
We assess Aleafia Health's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Aleafia Health has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

ALEF Future Performance

 How is Aleafia Health expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
95.2%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Aleafia Health expected to grow at an attractive rate?
  • Aleafia Health's earnings growth is expected to exceed the low risk savings rate of 1.9%.
Growth vs Market Checks
  • Aleafia Health's earnings growth is expected to exceed the Canada market average.
  • Aleafia Health's revenue growth is expected to exceed the Canada market average.
Annual Growth Rates Comparison
Raw Data
TSX:ALEF Future Growth Rates Data Sources
Data Point Source Value (per year)
TSX:ALEF Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts 95.2%
TSX:ALEF Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 91.3%
Canada Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 53.6%
Canada Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 16.8%
Canada Market Earnings Growth Rate Market Cap Weighted Average 14.6%
Canada Market Revenue Growth Rate Market Cap Weighted Average 5.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
TSX:ALEF Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
TSX:ALEF Future Estimates Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-12-31 297 71 38 1
2020-12-31 167 33 2 1
2019-12-31 21 -22 -55 1
TSX:ALEF Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-03-31 5 -19 -37
2018-12-31 3 -10 -19
2018-09-30 3 -4 -8
2018-06-30 1 -3 -5
2018-03-31 0 -3 -4
2017-12-31 0 -1 -11

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Aleafia Health's earnings are expected to grow significantly at over 20% yearly.
  • Aleafia Health's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
TSX:ALEF Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from Aleafia Health Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

TSX:ALEF Future Estimates Data
Date (Data in CAD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-12-31
2020-12-31
2019-12-31
TSX:ALEF Past Financials Data
Date (Data in CAD Millions) EPS *
2019-03-31 -0.27
2018-12-31 -0.16
2018-09-30 -0.08
2018-06-30 -0.06
2018-03-31 -0.07
2017-12-31 -0.26

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Aleafia Health will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Aleafia Health's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Aleafia Health has a total score of 5/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

ALEF Past Performance

  How has Aleafia Health performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Aleafia Health's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Aleafia Health does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.
  • Unable to compare Aleafia Health's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Aleafia Health's 1-year growth to the CA Healthcare industry average as it is not currently profitable.
Earnings and Revenue History
Aleafia Health's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Aleafia Health Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

TSX:ALEF Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 4.77 -37.08 38.83
2018-12-31 3.33 -18.53 20.94
2018-09-30 2.95 -8.33 9.74
2018-06-30 1.31 -5.30 5.79
2018-03-31 0.10 -4.04 4.06
2017-12-31 0.02 -10.57 10.52

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Aleafia Health has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Aleafia Health has efficiently used its assets last year compared to the CA Healthcare industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Aleafia Health improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Aleafia Health's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Aleafia Health has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

ALEF Health

 How is Aleafia Health's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Aleafia Health's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Aleafia Health is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Aleafia Health's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Aleafia Health's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 2.9x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Aleafia Health Company Filings, last reported 2 months ago.

TSX:ALEF Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 387.56 21.12 43.53
2018-12-31 91.93 0.00 26.41
2018-09-30 68.52 0.00 22.82
2018-06-30 63.32 0.00 29.09
2018-03-31 63.89 0.00 30.29
2017-12-31 10.92 4.00 1.06
  • Aleafia Health's level of debt (5.4%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if Aleafia Health's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Aleafia Health has sufficient cash runway for 1.2 years based on current free cash flow.
  • Aleafia Health has sufficient cash runway for 1.1 years if free cash flow continues to grow at historical rates of 197.3% each year.
X
Financial health checks
We assess Aleafia Health's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Aleafia Health has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

ALEF Dividends

 What is Aleafia Health's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Aleafia Health dividends.
If you bought CA$2,000 of Aleafia Health shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Aleafia Health's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Aleafia Health's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
TSX:ALEF Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
North America Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 25 Stocks 1.6%
Canada Market Average Dividend Yield Market Cap Weighted Average of 335 Stocks 3.6%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.2%
Canada Bottom 25% Dividend Yield 25th Percentile 2.1%
Canada Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

TSX:ALEF Future Dividends Estimate Data
Date (Data in CA$) Dividend per Share (annual) Avg. No. Analysts
2021-12-31
2020-12-31
2019-12-31

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Aleafia Health has not reported any payouts.
  • Unable to verify if Aleafia Health's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Aleafia Health's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Aleafia Health has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Aleafia Health's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Aleafia Health afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Aleafia Health has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

ALEF Management

 What is the CEO of Aleafia Health's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Geoff Benic
COMPENSATION CA$191,783
TENURE AS CEO 1 years
CEO Bio

Mr. Geoffrey Benic, also known as Geoff, has been Chief Executive Officer of Aleafia Health Inc since June 28, 2018. Previously, Mr. Benic served as the Regional Director of United Parcel Service Canada Ltd, Mr. Benic moved on to be an initial Grocery Gateway employee and General Manager. From October 2004 until June 2018, Mr. Benic was the founder and chairman of Sofilia Logistics Group Inc.

CEO Compensation
  • Insufficient data for Geoff to compare compensation growth.
  • Geoff's remuneration is lower than average for companies of similar size in Canada.
Management Team Tenure

Average tenure of the Aleafia Health management team in years:

0.8
Average Tenure
  • The average tenure for the Aleafia Health management team is less than 2 years, this suggests a new team.
Management Team

Geoff Benic

TITLE
Chief Executive Officer
COMPENSATION
CA$192K
TENURE
1 yrs

Benjamin Ferdinand

TITLE
CFO & Corporate Secretary
COMPENSATION
CA$171K
TENURE
0.8 yrs

Michael Verbora

TITLE
Chief Medical Officer
COMPENSATION
CA$111K
TENURE
1.2 yrs

Greg Rossi

TITLE
Chief Operating Officer
TENURE
0.8 yrs

Trevor Newell

TITLE
Chief Marketing & Technology Officer
TENURE
0.8 yrs

Geoff Smith

TITLE
General Counsel
TENURE
0.3 yrs

Nick Bergamini

TITLE
Vice President of Public Affairs
TENURE
0.8 yrs

Dave Shepherd

TITLE
Vice President of Human Resources
TENURE
0.4 yrs

Lucas Escott

TITLE
Head Horticulturist

Keith White

TITLE
President of Clinic Operations
TENURE
0.3 yrs
Board of Directors Tenure

Average tenure and age of the Aleafia Health board of directors in years:

1.1
Average Tenure
63
Average Age
  • The average tenure for the Aleafia Health board of directors is less than 3 years, this suggests a new board.
Board of Directors

Julian Fantino

TITLE
Chairman of the Board
COMPENSATION
CA$847K
AGE
75
TENURE
1.3 yrs

Mark Sandler

TITLE
Director
AGE
63
TENURE
1.2 yrs

Lea Ray

TITLE
Director
AGE
52
TENURE
0.7 yrs

Loreto Grimaldi

TITLE
Lead Independent Director
AGE
47
TENURE
0.2 yrs

Raf Souccar

TITLE
Director
COMPENSATION
CA$730K
AGE
61
TENURE
1.3 yrs

Bill Stewart

TITLE
Director
AGE
67
TENURE
1.1 yrs

Don Milliard

TITLE
Director
AGE
70
TENURE
0.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
15. Oct 18 Sell Michael Verbora Individual 12. Oct 18 12. Oct 18 -10,000 CA$3.03 CA$-30,300
26. Sep 18 Sell Gary Goodyear Individual 24. Sep 18 24. Sep 18 -60,000 CA$2.94 CA$-176,400
X
Management checks
We assess Aleafia Health's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Aleafia Health has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

ALEF News

Simply Wall St News

Why Aleafia Health Inc. (TSE:ALEF) Could Have A Place In Your Portfolio

By this I mean, I look at stocks holistically, from their financial health to their future outlook. … For those interested in digger a bit deeper into my commentary, take a look at the report on Aleafia Health here. … Excellent balance sheet with high growth potential Investors in search for stocks with room to flourish should look no further than ALEF, with its expected earnings growth of 95%.

Simply Wall St -

Did You Miss Aleafia Health's (TSE:ALEF) Impressive 183% Share Price Gain?

(TSE:ALEF) shareholders might be concerned after seeing the share price drop 18% in the last month. … Like an eagle, the share price soared 183% in that time. … Aleafia Health isn't a profitable company, so it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS).

Simply Wall St -

ALEF Company Info

Description

Aleafia Health Inc. operates as an integrated cannabis health and wellness company. It produces a portfolio of products, including oils, capsules, and sprays. The company also operates a network of 25 medical cannabis clinics; and education centers. Aleafia Health Inc. is headquartered in Concord, Canada.

Details
Name: Aleafia Health Inc.
ALEF
Exchange: TSX
Founded:
CA$357,182,434
274,755,719
Website: http://www.aleafiahealth.com
Address: Aleafia Health Inc.
8810 Jane Street,
2nd Floor,
Concord,
Ontario, L4K 2M9,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TSX ALEF Common Shares The Toronto Stock Exchange CA CAD 28. Mar 2018
OTCPK ALEA.F Common Shares Pink Sheets LLC US USD 28. Mar 2018
DB ARAH Common Shares Deutsche Boerse AG DE EUR 28. Mar 2018
Number of employees
Current staff
Staff numbers
187
Aleafia Health employees.
Industry
Health Care Facilities
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/06/16 00:58
End of day share price update: 2019/06/14 00:00
Last estimates confirmation: 2019/06/11
Last earnings filing: 2019/05/13
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.